J&J stops trials on drug to treat muscle-invasive bladder cancer
Johnson and Johnson discontinued a study of an investigational drug to treat bladder cancer after it failed to yield desired results
Drugs
Health
Medical
Drugs
Health
Pharma
Contineum’s test drug may reverse multiple sclerosis damage
Contineum Therapeutics, Inc., a US San Diego-headquartered biopharmaceutical company’s trial drug may reverse multiple sclerosis damage by potentially restoring movement and function.
Drugs
Health
Pharma
GSK’s blood cancer test drug halves risk of disease progression: Data
British drugmaker, GSK Plc.’s multiple myeloma drug, Blenrep, reduced the risk of disease progression or death by about 50% when compared to a.
Drugs
Medical
Pharma
Six African nations recall J&J manufactured cough syrup after suspicious toxicity reports
HQ Team April 17, 2024: Drug regulatory authorities in South Africa, Tanzania, Rwanda, Nigeria, Kenya, Eswatini and Zimbabwe have issued a recall for.
Drugs
Health
Pharma
USFDA green lights Janssen’s Talvey to treat multiple myeloma
HQ Team August 11, 2023: The USFDA has granted accelerated approval to Janssen Pharmaceutical Companies for its cancer antibody treatment, Talvey, to treat.
